Dialysis provider Fresenius Medical Care AG & Co. KGaA has acquired National Cardiovascular Partners. The parties involved agreed not to disclose the financial terms of the acquisition.

Fresenius said it expects National Cardiovascular Partners to generate more than $200 million in revenue in 2015 and expects the investment to be accretive to earnings in the first year after closing. The investment will be financed through available cash and committed credit facilities, supplemented by additional debt financing.

National Cardiovascular Partners provides endovascular, vascular and cardiovascular services in an outpatient setting. In partnership with more than 200 physicians, NCP operates 21 outpatient vascular centers in six states.

"The convenience of NCP's outpatient clinics and the excellent care they provide will enhance our ability to improve health outcomes for people with chronic illness, in particular those with renal and cardiovascular disease," Ron Kuerbitz, chief executive officer of Fresenius Medical Care North America said.